London, 11 July 2015 – Technavio has published a new report on the global carotid stent market, which is expected to grow at a CAGR of over 13% from 2015-2019.
About the Report
The new Technavio report highlights increased workloads, unhealthy diets, changing lifestyles, and physical inactivity as key causes leading to more cases of cardiac disorders, especially in the people aged 65 and over. Increased blood pressure, blood glucose, and lipids, can all lead to obesity, hypertension, abnormal cholesterol, and diabetes.
“In recent years, the incidence and prevalence of cardiovascular diseases such as stroke, myocardial infarction, and coronary artery disease have increased,” says Faisal Ghaus, Vice President of Technavio.
The latest report by Technavio also emphasizes carotid artery stenting, which is used in the treatment of high-risk symptomatic carotid artery stenosis.
“The procedure is a minimally invasive method, and many physicians are trying to make the procedure even safer, which will lead to its broader application for various cardiovascular diseases,” adds Ghaus.
Market Scope and Calculation of Market Size
The new Technavio report covers the present scenario and growth prospects of the global carotid stent market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of carotid stents.
Key Information Covered in the Report:
Key Vendors:
- Abbott Laboratories Inc.
- Boston Scientific Corp.
- Cordis Corp. (subsidiary of Johnson & Johnson)
- Medtronic plc
Market Growth Drivers:
- High Proportion of Elderly People
- For a full detailed list, view our report.
Market Challenges:
- Complications of Carotid Artery Stenting
- For a full detailed list, view our report.
Market Trends:
- Increase in Number of Clinical Trials
- For a full detailed list, view our report.
https://www.technavio.com/%3Cp%3ETechnavio%20currently%20has%20more%20tha…
